Synopsis
Since axonal injury is a primary outcome
of traumatic brain injury, our goal was to characterize its regional
distribution from a metabolic perspective. We set out to identify regions
prone to disproportionate injury, hence, candidate targets in potential clinical applications of proton
MR spectroscopy (1H-MRS). We found that metabolic axonal injury is
diffusely distributed among commonly injured tracts, but multivoxel 1H-MRS
may lack sensitivity for its detection on a regional basis. These results
motivate the use of 1H-MRS approaches with higher sensitivity, such
as global averaging, or large "single voxels" in areas of white matter,
irrespective of placement location.Introduction
In the United States, traumatic brain
injury (TBI) is the number one cause of neurological disability in young
adults. Most cases are classified as mild TBI (mTBI), which can result in
chronic post-concussive symptoms (PCS). Clinical management of mTBI patients,
unfortunately is rarely based on biomarkers, due to the lack of findings on
conventional imaging. Fortunately, quantitative MR techniques, such as diffusion
tensor imaging (DTI) and proton MR spectroscopy (
1H-MRS) have shown
microstructural and biochemical changes in normal-appearing tissue, motivating
research into their potential clinical use
1,2. Since axonal injury
is the primary TBI outcome, and has been extensively documented with DTI
1,3
and
1H-MRS
2, 4-7, our goal was to characterize its
regional distribution in order to identify regions prone to disproportionate
injury, hence, candidate targets for single-voxel or multi-voxel clinical
1H-MRS of mTBI. We utilized a dataset of PCS-positive patients in which we previously
showed diffuse axonal abnormalities, i.e.
lower global white matter (WM)
N-acetyl-aspartate (NAA)
levels compared to controls
8.
Methods
Subjects:
Fifteen PCS-positive mTBI patients (
Table 1)
and 12 age- and gender-matched controls.
Data acquisition: T1-weighted
MRI (MP-RAGE), T2-weighted MRI (FLAIR), B
0 shimming, 10×8×4.5 cm
(AP×LR×IS)=360 cm
3 1H-MRS VOI (PRESS TE/TR=35/1800 ms),
encoded to 480 voxels, each 1.0×1.0×0.75 cm
3 (
Fig. 1).
Metabolite quantification: Absolute amounts
of NAA, creatine (Cr), choline (Cho) and
myo-inositol
(mI) were obtained using phantom replacement with correction for T1 and T2
relaxation time differences between
in vivo and
in vitro.
Segmentation: Six WM regions (body, genu, splenium
of the corpus callosum, corona radiata, frontal and occipital WM) were manually
outlined in 3D on each patient's axial MP-RAGE images based on DTI atlas
parcellations
9, as shown in
Fig.
1 and
2. Global WM, gray matter
(GM) and cerebro-spinal fluid (CSF) masks were obtained from the MP-RAGE using
SPM.
Regional 1H-MRS: All masks were co-registered with the
1H-MRS
matrix, yielding their volume in every
1H-MRS voxel. This enabled CSF
and GM partial volume control: only voxels with <30% of each were retained
for subsequent analyses. Next, the goal was to ensure similar statistical precision
for the analysis of each WM region, since larger regions (e.g. corona radiata) would
normally contribute more voxels than smaller regions (e.g. genu), which would
translate into better precision for the former because of voxel averaging. To
avoid this scenario, we used similar number of voxels for each WM region by
determining the optimal trade-off between mask inclusion and number of selected
voxels. The resulting minimal voxel mask fractions used for each region were
40% for body, 50% for genu and splenium, 60% for occipital and 70% for corona
radiata. Finally, only voxels with metabolite Cramer-Rao lower bounds<20%
and 4<linewidths<13 Hz were included.
Statistics: Unpaired student t tests with Bonferroni correction for
multiple comparisons.
Results
The metabolic concentrations in each WM
region are shown in
Table 2, and
their distributions are plotted in
Fig.
3. There were no statistically significant differences in any metabolite between
patients and controls, in any WM region, even before correction for multiple
comparisons. However, as evident from
Fig.
3, the median NAA concentration
in each WM region was lower than controls’.
Discussion
The WM regions were selected on the basis
of being the most commonly injured, based on previous
1H-MRS
4-7,
DTI
3 and histopathology
10-12. The additional criterion
was that small tracts, unsuitable for the course spatial resolution of
1H-MRS
were not considered. We ensured similar statistical precision among all
comparisons, albeit at the cost of accuracy; however, this was an appropriate
trade-off for this study, which had the goal of comparing the ability of
1H-MRS
to detect injury amongst different regions. There were two main findings.
First, while there were no significant differences, NAA in patients was lower
across all WM regions. This indicated that metabolic axonal injury is truly
diffuse,
i.e. no region is spared,
but also no region sustains injury of much larger proportion than others.
Second, despite careful partial volume control, regional analysis of
multi-voxel data lacked the sensitivity to detect (the clearly present) regional
injury. This motivates the use of: (i) global WM multi-voxel approaches, which
benefit from increased sensitivity (i.e. precision) due to voxel averaging
13; or (ii) large volumes-of-interest (e.g.
single-voxels) in pure WM, without consideration of locale.
Conclusion
Metabolic axonal injury in mTBI is
diffusely distributed among commonly injured tracts, but multi-voxel
1H-MRS
may lack sensitivity for its detection on a regional basis. These results motivate
the use of
1H-MRS approaches with higher sensitivity, such as global
WM averaging, or large single-voxels in areas of pure WM, irrespective of placement
location.
Acknowledgements
This
work was supported by NIH grants NS050520, NS29029, EB01015 and the Center for
Advanced Imaging Innovation and Research (CAI2R, www.cai2r.net), a NIBIB
Biomedical Technology Resource Center (NIH P41 EB017183). Assaf Tal
acknowledges the support of the Monroy-Marks Career Development Fund, the
Carolito Stiftung Fund, the Leona M. and Harry B. Helmsley Charitable Trust and
the historic generosity of the Harold Perlman Family.References
1.
Shenton
ME, Hamoda HM, Schneiderman JS, Bouix S, Pasternak O, Rathi Y, Vu MA, Purohit
MP, Helmer K, Koerte I, Lin AP, Westin CF, Kikinis R, Kubicki M, Stern RA,
Zafonte R. A review of magnetic resonance imaging and diffusion tensor imaging
findings in mild traumatic brain injury. Brain Imaging Behav 2012;6:137-192.
2. Lin AP, Liao HJ, Merugumala SK, Prabhu SP,
Meehan WP, 3rd, Ross BD. Metabolic imaging of mild traumatic brain injury.
Brain Imaging Behav 2012;6:208-223.
3. Hulkower MB, Poliak DB, Rosenbaum SB,
Zimmerman ME, Lipton ML. A decade of DTI in traumatic brain injury: 10 years
and 100 articles later. AJNR Am J Neuroradiol 2013;34:2064-2074.
4. Gasparovic C, Yeo R, Mannell M, Ling J,
Elgie R, Phillips J, Doezema D, Mayer A. Neurometabolite Concentrations in Gray
and White Matter in Mild Traumatic Brain Injury: A 1HMagnetic Resonance
Spectroscopy Study. J Neurotrauma 2009.
5. Holshouser BA, Tong KA, Ashwal S, Oyoyo U,
Ghamsary M, Saunders D, Shutter L. Prospective longitudinal proton magnetic
resonance spectroscopic imaging in adult traumatic brain injury. J Magn Reson
Imaging 2006;24:33-40.
6. Aaen GS, Holshouser BA, Sheridan C, Colbert
C, McKenney M, Kido D, Ashwal S. Magnetic resonance spectroscopy predicts
outcomes for children with nonaccidental trauma. Pediatrics 2010;125:295-303.
7. Johnson B, Gay M, Zhang K, Neuberger T,
Horovitz SG, Hallett M, Sebastianelli W, Slobounov S. The use of magnetic
resonance spectroscopy in the subacute evaluation of athletes recovering from
single and multiple mild traumatic brain injury. J Neurotrauma 2012;29:2297-2304.
8. Kirov, I.I., Tal, A., Babb, J.S., Reaume,
J., Bushnik, T., Ashman, T.A., Flanagan, S., Grossman, R.I., Gonen, O., 2013.
Proton MR spectroscopy correlates diffuse axonal abnormalities with
post-concussive symptoms in mild traumatic brain injury. J. Neurotrauma 30,
1200–1204.
9. Mori, S., Wakana, S., Nagae-Poetscher, L.,
van Zijl, P., 2005. MRI Atlas of Human White Matter. 1st ed. Elsevier,
Amsterdam.
10. Browne KD, Chen XH, Meaney DF, Smith DH.
Mild traumatic brain injury and diffuse axonal injury in swine. J Neurotrauma
2011;28:1747-1755.
11. Cecil KM, Lenkinski RE, Meaney DF, McIntosh
TK, Smith DH. High-field proton magnetic resonance spectroscopy of a swine
model for axonal injury. J Neurochem 1998;70:2038-2044.
12. Mouzon B, Chaytow H, Crynen G, Bachmeier C,
Stewart J, Mullan M, Stewart W, Crawford F. Repetitive mild traumatic brain
injury in a mouse model produces learning and memory deficits accompanied by
histological changes. J Neurotrauma 2012;29:2761-2773.
13. Tal A,
Kirov II, Grossman RI, Gonen O. The role of gray and white matter segmentation
in quantitative proton MR spectroscopic imaging. NMR Biomed 2012;25:1392-1400.